|
| |
Dividend, Bonus, Split & Consolidation Hints : Click here to modify the Visible Columns.
  kk7198 @mileskoon, Harta is for long term as their management is cleaner...not like Topglove with Aspion saga and is far sighted like AMG which is getting approval from FDA in this year.Now is not virus theme play as the virus is peaking this month. 12/02/2020 7:25 AM T1T4N Its not about the virus cases drop or what. Whole world has HEALTH CONCIOUS UP LEVEL to MAXIMUM NOW. Olympic 2020 is at JAPAN, the most affected country outside china. Coming Euro2020 also (football) Do you think the demand will DROP due to virus case turn better? Think again. 12/02/2020 1:06 PM Chelsea Global glove demand surge where Malaysia order increase from 192B to 230B (additional 38B) which equivalent to half Top glove. This demand will continue grow due health concern awareness which arise from flu virus in US and COVID-19. As u can c, past 5 years the CAGR average is 12% compare with 7% on past decade. My target for Harta after include plant 6 is rm7 and plant 7 is rm7.8 CHELSEA 12/02/2020 2:17 PM kenie New coronavirus vaccine may be faster to develop KUALA LUMPUR (Feb 12): With the number of cases and deaths already surpassing that of SARS, teams around the world are racing to come up with a vaccine against the novel coronavirus (Covid-19). At the time of writing, the virus has infected 45,194 people and killed 1,114 others. Developing a vaccine safe for human use typically takes years, but there is reason to believe that the process will be speedier this time around, said academician and virologist Emeritus Prof Datuk Dr Lam Sai Kit. “Advances in technology now makes it possible to come up with candidate vaccines in a matter of weeks, unlike traditional methods which can take years,” he told Bernama when contacted. In addition to that, scientists in China sequenced the virus’s genome and made it available on Jan 10, just a month after the Dec 8 report of the first case of pneumonia from an unknown virus in Wuhan. In contrast, scientists took more than half a year to sequence the SARS coronavirus after the outbreak began in late 2002. How long will it take? Lam noted that although candidate vaccines may be available in a matter of weeks, it would take much longer for them to be evaluated for human use. “These candidate vaccines have to be tested in animal studies before human clinical trials can be started. It is still a long road ahead, and by the time a vaccine is ready, the outbreak may already be over — like in the case of SARS, where it took 20 months before a candidate vaccine was developed,” said Lam. The vaccine never made it to the market because the virus was successfully contained with public health measures. The vaccine against MERS, meanwhile, is still being developed. Immunologist Datuk Dr Musa Nordin said despite the pressure to come up with a vaccine as soon as possible, it must be noted that vaccine development remains an expensive and risky process. “On average, it takes 10 years from pre-clinical trials through Phase 1-3 clinical trials before it is proven efficacious and safe for registration by regulatory bodies and use in man. “However, the Covid-19 has the benefit of experience with previous candidate vaccines for MERS and SARS, allowing a jump start on the development of vaccines. If I had to hazard a best optimistic guess, I would say (a Covid-19 vaccine would be developed) within six months,” he said to Bernama. What if it mutates? One of the fears is that the Covid-19 would mutate after a vaccine is finally developed, affecting its efficacy. However, it should be noted that Covid-19 does not undergo the same type of genome shuffling as the influenza virus, which is constantly mutating. Like SARS, the genome of the Covid-19 comprises a single strand of RNA (ribonucleic acid). Microbes with such genome are known to mutate very quickly, but SARS has a molecular proofreading system that reduces its mutation rate. Given the similarity to SARS at the genomic level, it has been suggested that the Covid-19 would not be as prone to mutation as the flu virus, which comprises multiple single-stranded RNA segments. Therefore, if a vaccine is produced, it would still be effective. Lam said that mutation is always a possibility with RNA viruses like the Covid-19. “Usually, a major change happens when the virus jumps species. Hopefully, if there is a mutation, it will be a minor and not involving the spike protein, which is the important antigen used to produce the neutralising antibody in our immune system. “With minor changes, the vaccine will still offer protection, or modify the severity of the disease,” he said. CEPI The Coalition of Endemic Preparedness Innovations (CEPI) in January announced that it would be funding three programmes to develop vaccines against the 2019-nCov. It has engaged, among others, the Queensland University to work on a vaccine using its recently developed rapid response technology. The university’s head of School of Chemistry and Molecular Biosciences Prof Paul Young said that they would be using the novel technology, known as the molecular clamp, for the rapid generation of the vaccine. Young’s team of researchers have already experienced using this novel technology to produce candidate vaccines against influenza, Nipah, Ebola, and MERS. The team is optimistic that it will be able to develop the Covid-19 vaccine within six months. “We are working around the clock to produce enough of the spike proteins in cells to produce this sub-unit vaccine,” said Young in an email. A sub-unit vaccine is a fragment of a pathogen, typically a surface protein that is used to trigger an immune response. This in turn will stimulate acquired immunity against the pathogen from which it is derived. CEPI is a non-profit organisation formed in 2017 to fund vaccine development for emerging infectious diseases. It is based in Oslo, Norway, and is a global partnership created to spearhead development 12/02/2020 3:34 PM Alibaba Limskeong what happens to harta C28, mother up son go down, anyone know this.....? 12/02/2020 5:50 PM  James Ng https://klse.i3investor.com/blogs/general/2020-02-12-story-h1483791340.jsp [转贴] [Facebook live video:浅谈Hartalega holdings bhd (Harta)] - James的股票投资James Share Investing 12/02/2020 9:28 PM ching9 what happens to harta C28, mother up son go down, anyone know this.....? + 1 12/02/2020 5:50 PM Same enquiry , Anyone possible reason to share? 12/02/2020 11:50 PM James Ng https://klse.i3investor.com/blogs/general/2020-02-13-story-h1483791490.jsp [转贴] [HARTALEGA HOLDINGS BHD：第六工厂的第一条生产线已于2020年1月投入使用，其余生产线将逐步投产，以满足不断增长的需求；一旦建成，第六工厂的年产量将达到47亿个] - James的股票投资James Share Investing 13/02/2020 7:53 AM  cheeseburger looking at spiking up confirmed case hit 60k, is very unlikely the demand for gloves not follow suit. It will only go up not come down. The stock analysis really need do homework before you call it too expensive. It is reasonable with much higher demand flooding the counter. 13/02/2020 9:04 AM Jerichomy Pls dont accumulate now, my friend in adventa and ocncash told me that banker oredi left all the mask and glove counter...they are in steel counters...pls feel free to join them 13/02/2020 9:48 PM Chelsea lol Jerichomy don't listen to others. Please refer to the top 20 fund as closing 31 January 2020 where mostly new fund enter except Supermax. 14/02/2020 2:20 PM gggSTOCK dont listen to those stupid analyst, they got paid even if they write rubbish 14/02/2020 5:06 PM Rf888 Dont simply listen of analyst, please go do your own homework. Now china urgent need glove, next quarter result is very important. Please go study the result, you will get hint inside. In line with growing rubber glove demand globally, Hartalega will continue with its NGC capacity expansion plans. First line of Plant 6 was commissioned in January 2020 with remaining production lines to come on stream progressively to cater for the rising demand. Plant 6 will have an annual installed capacity of 4.7 billion pieces once completed. Plant 7 is also in the expansion pipeline catering to small orders, focusing more on specialty products and will have an annual installed capacity of 3.4 billion pieces. With the progressive commissioning of Plant 6 and 7, Hartalega’s annual installed capacity is expected to increase from the current 36.6 billion to 44.7 billion pieces by FY2022. 15/02/2020 1:50 PM Rf888 The virus will effect many industries, only glove counter is super safe now and the fundamental is super good compare with others industry. This is the time, see back the H1N1 time how the glove counter result? Dont simply sell out your glove counter, is time to win big. 15/02/2020 1:53 PM  probability no of new confirmed infections per day had been clearly dropping....: 5th Feb: 3927 6th Feb: 3723 7th Feb: 3163 8th Feb: 3437 9th Feb: 2676 10th Feb: 3001 11th Feb: 2546 12th Feb: 1970 13th Feb: 1819 14th Feb: 1995 15th Feb: 1500 ........... 90% of the above cases was in Hubei only, meaning only about 200 confirmed cases in China outside Hubei. I think the war on the virus internationally is over. what more today OUTSIDE China: ONLY 1 CASE reported! .................... 15/02/2020 1:55 PM probability may be can market in hubei only now...outside hubeis is only 200 confirmed cases per day... even hubei will be completely under control in a month 15/02/2020 2:04 PM Rf888 The real amount and you get the report amount at internet is big different, of course also hope this virus can get vaccine early. 15/02/2020 2:37 PM yoyo Glove counters heat should b over concurrently with the dropping rate of virus infected cases. Harta TP RM5.20 19/02/2020 12:16 PM WanUtama2015 Rf888, the China population is 1.4 billion ( 14亿 or 1400 million ), not 14 billion. 19/02/2020 3:32 PM  Gtrade yesterday new Covid-19 cases drop to 359. good sign but with 1400m China workforce and masses back to work, or released from quarantine, any sparks new clusters would swing the authority in panic mode again. This time it may even be too widespread to manage.For the next 6 monhs, heightened demand for gloves ,and hygien equipment will continue 20/02/2020 12:59 PM ttluck no need worry la.....glove stock quite stable altough virus gone with the wind...hehe....looking longer term 20/02/2020 5:41 PM presswood True, nx QR sure big green, epf will buy back after dividen, everywhere using glove, why worried 20/02/2020 7:49 PM T1T4N This is a Glove Stock. Not a Anti CoronaVirus stock. Health Conscious UP = Glove Stock UP. USD UP = Export Earnings UP (Glove) 21/02/2020 1:06 PM RiskToRich 100% agreed with T1T4N....The whole world had learned another round of lesson from recent Coronavirus , everyone everywhere every country getting more hygienic... Demand for sure will sudden surge with new mkt , existing glove users like doctor nurses will increase the frequency to change their hand glove .... 23/02/2020 9:17 AM icon123 Pharmaniaga experiencing a surge in demand for PPE like glove, mask as well flu vaccine/ medicine. https://klse.i3investor.com/blogs/icon123/2020-02-23-story-h1483913354-Corana_Flu_season_pushes_vaccine_demand_over_10_fold_says_Pharmaniaga.jsp 23/02/2020 10:35 AM selvanf1 Last few days progression of total cases in South Korea: Feb. 23: 602 cases (day still in progress) Feb. 22: 436 cases Feb. 21: 209 cases Feb. 20: 111 cases Feb. 19: 58 cases Feb. 18: 31 cases 23/02/2020 8:28 PM selvanf1 55 new cases in Italy, including 2 new cases in Venice, a 17-year-old male in Valtellina, and a couple in Turin who visited their child at the Regina Margherita Hospital yesterday. Current total cases in Italy: - 90 cases in Lombardy region (including 1 death). - 26 in Veneto region (including 1 death). - 9 in Emilia Romagna region. - 6 in Piedmont region. - 3 in Rome (including 2 recoveries). Source:https://www.worldometers.info/coronavirus/ 23/02/2020 8:30 PM F1Trade Get ready to fly. Fear of coronavirus outside China increasing, glove increasing. Another wave for all Glove Counter coming soon. 25/02/2020 6:34 AM  |
|
